Impact Vector: AI Tools — 2026-04-17

Impact Vector: AI Tools · Apr 17, 2026 · 3m

## Short Segments ## Feature Story OpenAI has unveiled GPT-Rosalind, its first AI model specifically designed for the life sciences, aiming to revolutionize drug discovery and genomics research. Drug discovery is notoriously expensive and time-consuming, often taking 10 to 15 years from target discovery to regulatory approval in the United States. Much of this time is consumed by the meticulous analytical work required to sift through vast amounts of literature, design reagents, and interpret complex biological data. OpenAI's new model, GPT-Rosalind, seeks to address these challenges by…